http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2557917-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1df2628aa59a68fe9ccb02238e04ba6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0042 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 |
| filingDate | 2012-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec958acb513cdfdef2b9f81bdb8b2936 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a27181b5d8e09712e921870fce88a22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5ea969524e7c4459c5ea818d4996e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce86a67cfaaeb22204f8428fdfca0dfb |
| publicationDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2557917-C2 |
| titleOfInvention | Medical absorable haemostatic material for osteal wounds and method for producing |
| abstract | FIELD: medicine. n SUBSTANCE: group of inventions refers to medicine. What is described is a medical absorbable haemostatic and wound healing material for osteal wounds and a method for producing it. The absorbable haemostatic material for osteal wounds contains 40-95% of a primary material and 5-60% of an auxiliary on the basis of weight percentage, wherein the primary material contains an oligosaccharide, a polysaccharide or a mixture of the oligosaccharide and polysaccharide, while the auxiliary contains (1) one or more polyatomic alcohols, (2) one or more emulsifiers. The method for producing the absorbable haemostatic and wound healing material for osteal wounds consists of the following stages involving mixing the primary material and auxiliary in the pre-set amounts by chemical mixture and preparation of the mixture at the stage of latex, and cooling to form a solid piece, packaging and sterilising. n EFFECT: material is degradable in the body and promotes osteal wound healing. n 7 cl, 4 tbl, 9 ex |
| priorityDate | 2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.